Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eldelumab in Active Crohn's Disease
NCT01466374Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2011
- Primary completion
- Jun 2014
- Modality
- Monoclonal Antibodies
- Countries
- 8
01
Overview
A Phase 2 trial of eldelumab in Crohn's disease, sponsored by Bristol Myers Squibb. Started Dec 2011; status: completed.
02
Drugs
eldelumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01466374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01466374.